Form 4: Richard N. Altice, Interim CEO of Danimer Scientific, Receives Stock Appreciation Rights

Interim CEO Richard N. Altice was granted stock appreciation rights for 300,000 shares of Danimer Scientific's Class A common stock.

Summary

• Richard N. Altice, the Interim CEO of Danimer Scientific, Inc., received stock appreciation rights (SARs) on October 14, 2024.
• The SARs are for 300,000 shares of the company's Class A common stock.
• These rights were granted under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan.
• The SARs will vest and become exercisable on October 14, 2025, contingent upon Altice's continued service as a director of the company.
• The exercise price of the SARs is $0.55.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed neutrally to positively as it incentivizes management. The sentiment is moderately positive due to the alignment of interests between management and shareholders.

Positives

• The granting of stock appreciation rights to the Interim CEO aligns his interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company.

Industry Context

Stock appreciation rights are a common form of executive compensation used to align management's interests with those of shareholders. This grant is typical for incentivizing leadership within publicly traded companies.

Comparison to Industry Standards

• Stock appreciation rights are a common component of executive compensation packages in publicly traded companies, particularly in growth-oriented sectors.
• Companies like Amyris and Avantium, which are also focused on bio-based materials, often use similar equity-based incentives to attract and retain key personnel.
• The vesting schedule and exercise price are generally benchmarked against industry peers to ensure competitiveness and alignment with performance goals.

Stakeholder Impact

• Shareholders may view this as a positive sign, as it incentivizes the Interim CEO to improve the company's performance.
• Employees may see this as a sign of stability and commitment from the leadership.

Key Dates

Keywords

Stock Appreciation Rights, SARs, Danimer Scientific, DNMR, Richard N. Altice, Interim CEO, Incentive Plan, Equity Compensation, Form 4